Cardiovascular disease continues to be the leading cause of death in the United States. One out of every three deaths in the US is related to cardiovascular disease. Nearly half of all heart attacks have no prior risk that would indicate the individual is in jeopardy of experiencing a cardiac event. Critical factors of cardiac risk assessment include the individual’s personal and family history as well as laboratory test markers. Individuals who can potentially benefit from laboratory test assessment include those with diabetes, high blood pressure, poor diet, smokers, overweight/obese, lack of exercise, and advancing age.
The Evexia Basic Cardiovascular Panel is the first-line test to consider for assessing cardiovascular health. It measures the lipid profile via NMR, magnesium, and apolipoprotein assessment, as well as the CBC and comprehensive metabolic panel. This panel reports on health markers that indicate kidney and liver function, blood glucose regulation (via assessment of insulin, blood glucose, and hemoglobin A1c), and inflammation.